Literature DB >> 15246565

Antisense-mediated VEGF suppression in bladder and breast cancer cells.

Yvonne Förster1, Axel Meye, Sabine Krause, Bernd Schwenzer.   

Abstract

Angiogenesis plays a key role in tumor growth and metastasis. Vascular endothelial growth factor (VEGF) is one of the major angiogenic factors. In the study we have evaluated the efficiency of antisense oligodeoxynucleotides (AS-ODN) against VEGF selected from computational prediction of VEGF mRNA structure. Twenty-five different AS-ODN in two different tumor cell lines were investigated. Treatment of cell line EJ28 by VEGF723 resulted in a 83.5% suppression of VEGF protein when compared with control-ODN. Three further AS-ODN reduced VEGF protein more than 45% in comparison to control-ODN. This was caused by an antisense-specific downregulation of the VEGF transcript determined by real-time PCR. Furthermore, antisense-mediated inhibition of VEGF was associated by a reduced cell viability. In MCF-7 cells VEGF protein was inhibited more than 45% by two AS-ODN. In conclusion, we found that computational prediction of potential single strand mRNA motifs is a well suitable method to elect effective AS-ODN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246565     DOI: 10.1016/j.canlet.2004.02.020

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Gemcitabine and paclitaxel suppress the production of vascular endothelial growth factor induced by deferoxamine in human non-small cell lung cancer A549 cells.

Authors:  Ryuji Ikeda; Lee C Vermeulen; Zhisheng Jiang; Elim Lau; Jill M Kolesar
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

Review 2.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

3.  The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.

Authors:  Yousef H Aldebasi; Arshad H Rahmani; Amjad A Khan; Salah Mesalhy Aly
Journal:  Int J Clin Exp Med       Date:  2013-04-12

4.  New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.

Authors:  O A Patutina; N L Mironova; V V Vlassov; M A Zenkova
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

5.  Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubes.

Authors:  Anika Kaufmann; Silke Hampel; Christiane Rieger; David Kunhardt; Darja Schendel; Susanne Füssel; Bernd Schwenzer; Kati Erdmann
Journal:  J Nanobiotechnology       Date:  2017-07-17       Impact factor: 10.435

Review 6.  Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics.

Authors:  Bao T Le; Prithi Raguraman; Tamer R Kosbar; Susan Fletcher; Steve D Wilton; Rakesh N Veedu
Journal:  Mol Ther Nucleic Acids       Date:  2018-11-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.